Mode
Text Size
Log in / Sign up

Higher cumulative inflammatory-metabolic index linked to increased risk of rapid kidney function decline in older adults

Higher cumulative inflammatory-metabolic index linked to increased risk of rapid kidney function dec…
Photo by National Institute of Allergy and Infectious Diseases / Unsplash
Key Takeaway
Consider monitoring cumulative inflammatory-metabolic indices as potential markers for kidney function decline risk in older adults.

This cohort study analyzed data from 6,888 middle-aged and older adults (aged 45+) from the China Health and Retirement Longitudinal Study and National Health and Nutrition Examination Survey over a four-year period. Researchers examined the association between cumulative changes in the C-reactive protein-triglyceride glucose index (cuCTI) and CTI control levels with the incidence of rapid kidney function decline (RKFD).

During follow-up, 262 participants (3.8%) developed RKFD. Each one-unit increase in cuCTI was associated with an 18% higher risk of RKFD (OR = 1.18, 95% CI: 1.13–1.22). Higher CTI levels were also associated with lower eGFR, though specific effect sizes and absolute numbers for this secondary outcome were not reported.

Safety and tolerability data were not reported. The study's limitations were not specified in the provided information, and funding sources or conflicts of interest were not reported. Sensitivity analyses confirmed the stability of these associations across datasets.

As an observational study, these findings demonstrate association rather than causation. The results suggest that monitoring long-term inflammatory and metabolic status through indices like cuCTI may help identify middle-aged and older adults at risk for renal function decline, though clinical utility requires further validation.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
BackgroundRapid kidney function decline (RKFD) is an early indicator of chronic kidney disease and a precursor to kidney failure, yet early detection is challenging. Inflammation and metabolic imbalance may cause kidney damage, and the C-reactive protein–triglyceride glucose index (CTI) represents both factors. This study aims to explore the associations of cumulative changes of CTI (cuCTI) with RKFD risk in middle-aged and older adults.MethodsWe analyzed data from 6,888 individuals aged 45 and older from the 2011 and 2015 China Health and Retirement Longitudinal Study (CHARLS). Using multivariate logistic regression models, we explored the association between cuCTI, CTI control levels, and RKFD risk. We also used restricted cubic spline (RCS) models for dose-response patterns and conducted subgroup analyses based on sex, education, smoking, alcohol use, hypertension, diabetes, dyslipidemia, and CKD stage. Sensitivity analyses were performed on original, imputed, and pooled datasets to ensure robust results. A supplementary cross-sectional analysis using National Health and Nutrition Examination Survey analysis (NHANES) data examined the association between CTI and eGFR using weighted linear regression and RCS models.ResultsOver a four-year period, 262 participants (3.8%) developed RKFD. Increased cuCTI and poor CTI control were linked to a higher RKFD risk, with each one-unit cuCTI increase raising the odds by 18% (OR = 1.18, 95% CI: 1.13–1.22). Those with consistently high or rising CTI faced the greatest risk. The dose-response curve indicated a linear increase in RKFD risk with higher cuCTI, and subgroup analyses showed consistent results across all groups. Sensitivity analyses confirmed the stability of these associations across datasets. Similar associations were observed in the supplementary analysis using NHANES data, with higher CTI levels associated with lower eGFR.ConclusionHigher cumulative CTI levels were associated with an increased risk of rapid kidney function decline, and the association was most pronounced among individuals with persistently high CTI levels. Monitoring long-term inflammatory and metabolic status may help identify individuals at risk of renal function decline in middle-aged and older adults.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.